NEW YORK (360Dx) – A new collaboration was announced today aimed at shedding light on differences in type 2 diabetes.

Roche Diagnostics, Eli Lilly, the Indiana Biosciences Research Institute, the Regenstrief Institute, and Indiana University School of Medicine are collaborating to better understand how T2D varies among patients, with the goal of developing improved diagnostic tools and new treatments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.